CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphoma

A prospective randomized trial

平山 克, 森 昌造 · Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) · 1995 · 1.6K citations · Full text

Clinical Trial Design, Clinical Trial Management, Clinical Trials +4

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

Christian Steidl, Tang Lee, Sohrab P. Shah et al. · New England Journal of Medicine · 2010 · 1.3K citations · Full text

Outcome in Hodgkin's Lymphoma Can Be Predicted from the Presence of Accompanying Cytotoxic and Regulatory T Cells

Tomás Álvaro, Marylène Lejeune, Teresa Salvadó-Usach et al. · Clinical Cancer Research · 2005 · 448 citations

Tumor-Associated Macrophages: The Double-Edged Sword in Cancer Progression

Jeremy J.W. Chen, Yi‐Chen Lin, Pei‐Li Yao et al. · Journal of Clinical Oncology · 2004 · 372 citations · Full text

Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome

Bruno Chetaille, François Bertucci, Pascal Finetti et al. · Blood · 2008 · 250 citations